Cart
sales@molnova.com
Levofloxacin Hydrochloride Impurity A
CAS No. 2254176-11-7
Levofloxacin Hydrochloride Impurity A( Levofloxacin Hydrochloride Impurity A(117707-40-1 Free base) )
Catalog No. M26150 CAS No. 2254176-11-7
Levofloxacin Hydrochloride Impurity A I, one of the quinolones, has a broad spectrum of antibacterial action.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 212 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 283 | In Stock |
|
| 25MG | 452 | In Stock |
|
| 50MG | 631 | In Stock |
|
| 100MG | 848 | In Stock |
|
| 200MG | 1135 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLevofloxacin Hydrochloride Impurity A
-
NoteResearch use only, not for human use.
-
Brief DescriptionLevofloxacin Hydrochloride Impurity A I, one of the quinolones, has a broad spectrum of antibacterial action.
-
DescriptionLevofloxacin Hydrochloride Impurity A I, one of the quinolones, has a broad spectrum of antibacterial action.
-
In Vitro——
-
In Vivo——
-
SynonymsLevofloxacin Hydrochloride Impurity A(117707-40-1 Free base)
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2254176-11-7
-
Formula Weight397.83
-
Molecular FormulaC18H21ClFN3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)C1=CN2[C@H](COC3=C(C(F)=CC(C1=O)=C23)N4CCN(CC4)C)C.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cristina Cruz-Hernandez, et al. Direct quantification of fatty acids in human milk by gas chromatography. J Chromatogr A. 2013 Apr 5;1284:174-9.
molnova catalog
related products
-
Iclaprim
Iclaprim is a novel specific bacterial Dihydrofolate inhibitor.
-
Terminolic acid
Terminolic acid is a pentacyclic triterpenoid glucoside isolated from Combretum racemosum,?can inhibit the pro-inflammatory cytokines by binding to receptor active site of IL-1β and IL-6, and enhance anti-inflammatory cytokines by binding to IL-4 receptor binding sites.
-
Moxifloxacin
A fourth-generation synthetic fluoroquinolone, broad-spectrum antibacterial agent that is active against both Gram-positive and Gram-negative bacteria.
